X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (328) 328
female (271) 271
obstetrics & gynecology (169) 169
index medicus (152) 152
leuprolide acetate (140) 140
adult (115) 115
leuprolide acetate depot (110) 110
endometriosis (109) 109
male (94) 94
double-blind (86) 86
depot (80) 80
leuprolide - therapeutic use (79) 79
women (79) 79
gonadotropin-releasing hormone - agonists (74) 74
pharmacology & pharmacy (74) 74
endometriosis - drug therapy (72) 72
leuprolide (70) 70
middle aged (69) 69
depot medroxyprogesterone acetate (63) 63
reproductive biology (62) 62
leuprolide - administration & dosage (61) 61
leiomyoma - drug therapy (60) 60
uterine neoplasms - drug therapy (60) 60
gonadotropin-releasing hormone - analogs & derivatives (59) 59
therapy (58) 58
prostatic neoplasms - drug therapy (57) 57
treatment outcome (57) 57
delayed-action preparations (56) 56
prostate cancer (53) 53
urology & nephrology (53) 53
endocrinology & metabolism (50) 50
efficacy (47) 47
care and treatment (45) 45
testosterone (45) 45
gonadotropin-releasing hormone - therapeutic use (44) 44
animals (43) 43
fibroids (43) 43
danazol (42) 42
hormone agonist (41) 41
antineoplastic agents, hormonal - therapeutic use (40) 40
luteinizing hormone - blood (40) 40
symptomatic endometriosis (40) 40
leiomyoma - surgery (39) 39
time factors (39) 39
depot leuprolide (38) 38
gnrh agonist (38) 38
uterine neoplasms - surgery (38) 38
testosterone - blood (37) 37
bone-mineral density (36) 36
depot leuprolide acetate (36) 36
management (36) 36
aged (35) 35
child (35) 35
analog (34) 34
leuprolide - adverse effects (34) 34
pelvic pain (34) 34
gonadotropin-releasing-hormone (33) 33
estradiol - blood (32) 32
agonist (31) 31
endometriosis - complications (31) 31
medroxyprogesterone acetate (30) 30
puberty, precocious - drug therapy (30) 30
suppression (30) 30
acetate (29) 29
gonadotropin-releasing hormone (29) 29
hormones (29) 29
pain (29) 29
prospective studies (29) 29
uterine leiomyomata (29) 29
antineoplastic agents, hormonal - administration & dosage (28) 28
chronic pelvic pain (28) 28
medicine, general & internal (28) 28
surgery (28) 28
uterine neoplasms - pathology (28) 28
hysterectomy (27) 27
leiomyoma - pathology (27) 27
3-month depot (26) 26
central precocious puberty (26) 26
estrogen (26) 26
gonadotropin-releasing hormone - antagonists & inhibitors (26) 26
laparoscopy (26) 26
obstetrics and gynecology (26) 26
adolescent (25) 25
analysis (25) 25
cancer (25) 25
double-blind method (25) 25
progestins - therapeutic use (25) 25
depot formulation (24) 24
quality-of-life (24) 24
follicle stimulating hormone - blood (23) 23
injections, subcutaneous (23) 23
internal medicine (23) 23
leuprorelin (23) 23
retrospective studies (23) 23
children (22) 22
endometriosis - therapy (22) 22
leuprorelin acetate (22) 22
precocious puberty (22) 22
recurrence (22) 22
bone density - drug effects (21) 21
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Reproduction, ISSN 0268-1161, 01/2006, Volume 21, Issue 1, pp. 248 - 256
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 11/2007, Volume 16, Issue 11, pp. 1851 - 1863
Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications,... 
leuprolide acetate | uterine leiomyomata | central precocious puberty | endometriosis | short stature | contraception | polycystic ovary syndrome | gonadotropin-releasing hormone | prostate cancer | GnRH analog | functional bowel disease | gonadotropin-releasing hormone receptor | in vitro fertilization | premenstrual syndrome | Alzheimer's disease | Polycystic ovary syndrome | Functional bowel disease | Leuprolide acetate | Gonadotropin-releasing hormone receptor | Short stature | Uterine leiomyomata | Endometriosis | Contraception | In Vitro fertilization | Gonadotropin-releasing hormone | Prostate cancer | Central precocious puberty | POLYCYSTIC-OVARY-SYNDROME | GONADOTROPIN-RELEASING-HORMONE | ADVANCED PROSTATE-CANCER | LUTEINIZING-HORMONE | PHARMACOLOGY & PHARMACY | IN-VITRO FERTILIZATION | RAT MAMMARY-TUMORS | DEPOT LEUPROLIDE | FUNCTIONAL BOWEL-DISEASE | LONG-TERM TREATMENT | Receptors, LHRH - agonists | Humans | Male | Endometriosis - drug therapy | Gonadotropin-Releasing Hormone - analogs & derivatives | Puberty, Precocious - drug therapy | Fertility Agents, Female - therapeutic use | Animals | Gonadotropin-Releasing Hormone - metabolism | Leiomyoma - drug therapy | Leuprolide - therapeutic use | Female | Leuprolide - adverse effects | Gonadotropin-Releasing Hormone - agonists | Leuprolide - pharmacology | Prostatic Neoplasms - drug therapy
Journal Article
Journal Article
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, ISSN 2042-6305, 04/2019, Volume 8, Issue 5, pp. 337 - 355
To assess the cost-effectiveness of elagolix versus leuprolide acetate in women with moderate to severe endometriosis pain. Methods: A Markov model was... 
leuprolide acetate | DEPOT MEDROXYPROGESTERONE ACETATE | elagolix | dysmenorrhea | HYSTERECTOMY | endometriosis | nonmenstrual pelvic pain | cost-effectiveness model | ECONOMIC BURDEN | INCREMENTAL DIRECT | WOMEN | RATES | THERAPY | HEALTH CARE SCIENCES & SERVICES | COMPLICATIONS | QUALITY-OF-LIFE | HEALTH-CARE UTILIZATION
Journal Article
Clinical Breast Cancer, ISSN 1526-8209, 10/2018, Volume 18, Issue 5, pp. e939 - e942
The efficacy of leuprolide depot in combination with an aromatase inhibitor delivered monthly compared to once every 3 months in premenopausal women with... 
Ovarian suppression | GnRH analog | Aromatase inhibitor | DEPOT | ONCOLOGY | ACETATE | Safety and security measures | Menopause | Leuprolide | Breast cancer | Dosage and administration | Research | Drug therapy
Journal Article
Journal of Pediatric Endocrinology and Metabolism, ISSN 0334-018X, 11/2016, Volume 29, Issue 11, pp. 1249 - 1257
Background: Peak gonadotropin-releasing hormone or agonist (GnRHa) stimulated luteinizing hormone (LH) testing with leuprolide acetate (LA) is commonly used to... 
gonadotropin-releasing hormone | leuprolide acetate | luteinizing hormone | puberty, precocious | precocious | puberty | DIAGNOSIS | MANAGEMENT | DEPOT | CHILDREN | STATURAL GROWTH | ENDOCRINOLOGY & METABOLISM | ASSAYS | PEDIATRICS | Testis - metabolism | Humans | Follicle Stimulating Hormone, Human - antagonists & inhibitors | Male | Reproductive Control Agents - adverse effects | Luteinizing Hormone - metabolism | Reproductive Control Agents - therapeutic use | Puberty, Precocious - drug therapy | Testis - drug effects | Delayed-Action Preparations - administration & dosage | Dose-Response Relationship, Drug | Microspheres | Follicle Stimulating Hormone, Human - metabolism | Leuprolide - administration & dosage | Luteinizing Hormone - antagonists & inhibitors | Reproductive Control Agents - administration & dosage | Female | Ovary - drug effects | Retrospective Studies | Child | Gonadotropin-Releasing Hormone - agonists | Ovary - metabolism | Hypothalamo-Hypophyseal System - drug effects | Drug Administration Schedule | Luteinizing Hormone - blood | Follicle Stimulating Hormone, Human - blood | Hypothalamo-Hypophyseal System - metabolism | Delayed-Action Preparations - adverse effects | Leuprolide - therapeutic use | Delayed-Action Preparations - therapeutic use | Leuprolide - adverse effects | Puberty, Precocious - blood | Drug Monitoring | Measurement | Luteinizing hormone | Care and treatment | Dosage and administration | Leuprolide | Precocious puberty
Journal Article
Therapeutic Advances in Urology, ISSN 1756-2872, 2/2018, Volume 10, Issue 2, pp. 43 - 50
Background: The aim of this study was to compare the pharmacokinetics (PK) and pharmacodynamics (PD) of two distinct formulations of leuprolide acetate (LA);... 
leuprorelin | pharmacokinetics | ELIGARD | testosterone | ATRIGEL | ATRIGEL (R) | 3-MONTH DEPOT | SAFETY | TESTOSTERONE SUPPRESSION | ADVANCED PROSTATE-CANCER | ANDROGEN-DEPRIVATION THERAPY | DELIVERY-SYSTEM | ELIGARD (R) | DEPOT FORMULATION | UROLOGY & NEPHROLOGY | HORMONE AGONIST
Journal Article